These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 16988205)
1. Disposition and metabolite kinetics of oral L-carnitine in humans. Bain MA; Milne RW; Evans AM J Clin Pharmacol; 2006 Oct; 46(10):1163-70. PubMed ID: 16988205 [TBL] [Abstract][Full Text] [Related]
2. Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism. Rebouche CJ Ann N Y Acad Sci; 2004 Nov; 1033():30-41. PubMed ID: 15591001 [TBL] [Abstract][Full Text] [Related]
3. L-Carnitine in the treatment of fatigue in adult celiac disease patients: a pilot study. Ciacci C; Peluso G; Iannoni E; Siniscalchi M; Iovino P; Rispo A; Tortora R; Bucci C; Zingone F; Margarucci S; Calvani M Dig Liver Dis; 2007 Oct; 39(10):922-8. PubMed ID: 17693145 [TBL] [Abstract][Full Text] [Related]
4. Disposition of L-carnitine and acetyl-L-carnitine in the isolated perfused rat kidney. Mancinelli A; Longo A; Shanahan K; Evans AM J Pharmacol Exp Ther; 1995 Sep; 274(3):1122-8. PubMed ID: 7562478 [TBL] [Abstract][Full Text] [Related]
5. Excretion and metabolism of propionyl-L-carnitine in the isolated perfused rat kidney. Evans AM; Mancinelli A; Longo A J Pharmacol Exp Ther; 1997 Jun; 281(3):1071-6. PubMed ID: 9190838 [TBL] [Abstract][Full Text] [Related]
6. Oral L-carnitine: metabolite formation and hemodialysis. Bain MA; Faull R; Milne RW; Evans AM Curr Drug Metab; 2006 Oct; 7(7):811-6. PubMed ID: 17073580 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of L-arginine during chronic administration to patients with hypercholesterolaemia. Tangphao O; Chalon S; Moreno H; Hoffman BB; Blaschke TF Clin Sci (Lond); 1999 Feb; 96(2):199-207. PubMed ID: 9918901 [TBL] [Abstract][Full Text] [Related]
8. Effects of dietary ruminally protected L-carnitine on plasma metabolites in sheep following a sub-lethal ammonia challenge. Walker DK; Lambert BD; Woodworth JC J Anim Physiol Anim Nutr (Berl); 2005 Dec; 89(11-12):413-8. PubMed ID: 16401193 [TBL] [Abstract][Full Text] [Related]
9. Effect of methanol on endogenous and exogenous carnitine levels in rat plasma. Olszowy Z; Czech E; Nowicka J Arch Toxicol; 2005 Oct; 79(10):571-81. PubMed ID: 15889238 [TBL] [Abstract][Full Text] [Related]
10. Oral carnitine therapy in children with cystinosis and renal Fanconi syndrome. Gahl WA; Bernardini I; Dalakas M; Rizzo WB; Harper GS; Hoeg JM; Hurko O; Bernar J J Clin Invest; 1988 Feb; 81(2):549-60. PubMed ID: 3276734 [TBL] [Abstract][Full Text] [Related]
11. Influence of dietary L-carnitine and chromium picolinate on blood hormones and metabolites of gestating sows fed one meal per day. Woodworth JC; Tokach MD; Nelssen JL; Goodband RD; Dritz SS; Koo SI; Minton JE; Owen KQ J Anim Sci; 2007 Oct; 85(10):2524-37. PubMed ID: 17565063 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease. Smith WB; Dowell JA; Pratt RD Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688 [TBL] [Abstract][Full Text] [Related]
13. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
14. An inhibitory metabolite leads to dose- and time-dependent pharmacokinetics of (R)-N-{1-[3-(4-ethoxy-phenyl)-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl]-ethyl}-N-pyridin-3-yl-methyl-2-(4-trifluoromethoxy-phenyl)-acetamide (AMG 487) in human subjects after multiple dosing. Tonn GR; Wong SG; Wong SC; Johnson MG; Ma J; Cho R; Floren LC; Kersey K; Berry K; Marcus AP; Wang X; Van Lengerich B; Medina JC; Pearson PG; Wong BK Drug Metab Dispos; 2009 Mar; 37(3):502-13. PubMed ID: 19088267 [TBL] [Abstract][Full Text] [Related]
15. Dramatic decrease of carnitine esters after interruption of exogenous carnitine supply in hemodialysis patients. Bene J; Csiky B; Wittmann I; Sulyok E; Melegh B Ren Fail; 2012; 34(5):555-8. PubMed ID: 22417076 [TBL] [Abstract][Full Text] [Related]
16. Plasma and urine pharmacokinetics of free and of short-chain carnitine after administration of carnitine in man. Segre G; Bianchi E; Corsi M; D'Iddio S; Ghirardi O; Maccari F Arzneimittelforschung; 1988 Dec; 38(12):1830-4. PubMed ID: 3245856 [TBL] [Abstract][Full Text] [Related]
17. Dose-dependent pharmacokinetics and renal handling of zomepirac in rhesus monkeys. O'Neill PJ; Yorgey KA; McKown LA J Pharmacol Exp Ther; 1981 Dec; 219(3):665-8. PubMed ID: 7299689 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of propionyl-L-carnitine in humans: evidence for saturable tubular reabsorption. Pace S; Longo A; Toon S; Rolan P; Evans AM Br J Clin Pharmacol; 2000 Nov; 50(5):441-8. PubMed ID: 11069438 [TBL] [Abstract][Full Text] [Related]
19. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment. Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study. Lim KS; Kim JR; Choi YJ; Shin KH; Kim KP; Hong JH; Cho JY; Shin HS; Yu KS; Shin SG; Kwon OH; Hwang DM; Kim JA; Jang IJ Clin Ther; 2008 Oct; 30(10):1817-30. PubMed ID: 19014837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]